Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tarek Zoheir, Tawfik"'
Autor:
Alshaimaa Mahmoud Aboulfotooh, Salwa Tawfik, Montasser M Hegazy, Heba Sayed Assal, Shaimaa I. El-Jaafary, Sherif Elwan, Tarek Zoheir Tawfik, Foad Abd-Allah
Publikováno v:
World Journal of Cardiovascular Diseases. :8-13
Background: The metabolic syndrome (MetS) is a clustering of vascular risk factors that tend to increase the risk of occurrence of diabetes mellitus type 2 (DMT2), cardiovascular and cerebro-vascular ischemic events. The aim of the present study is t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8be9bf993d2409bdcefb0a0e8952a876
https://doi.org/10.4236/wjcd.2016.61002
https://doi.org/10.4236/wjcd.2016.61002
Autor:
Eslam El Nahrery, Hebatalla Hashem, Nawal F. Abdel Ghaffar, Hatem S Shehata, Adel H. Gad, Nevin M. Shalaby, Dina A. Mehaney, Tarek Zoheir Tawfik
Publikováno v:
Journal of the neurological sciences. 378
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2b2334db76103f2ac9d5344e5f07552
https://pubmed.ncbi.nlm.nih.gov/27653861
https://pubmed.ncbi.nlm.nih.gov/27653861
Autor:
Foad, Abd-Allah, Tarek Zoheir, Tawfik, Reham Mohammed, Shamloul, Montasser M, Hegazy, Assem, Hashad, Ayman Ismail, Kamel, Dina, Farees, Nevin M, Shalaby
Publikováno v:
Journal of vascular and interventional neurology. 9(1)
Patients with transient ischemic attack (TIA) are generally clinically unstable, with fear of developing a handicapping stroke. Identification of those at highest and lowest risk of stroke in the first days and weeks after a TIA would allow appropria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ab52225f1fcb9110bcc77c8adac6e89f
https://pubmed.ncbi.nlm.nih.gov/27403225
https://pubmed.ncbi.nlm.nih.gov/27403225
Autor:
Hatem S Shehata, Hebatalla Hashem, Nawal F. Abdel Ghaffar, Nevin M. Shalaby, Eslam El Nahrery, Tarek Zoheir Tawfik, Dina A. Mehaney, Adel H. Gad
Publikováno v:
Journal of the neurological sciences. 369
Background Cytokines are major contributors in the immune disruption in multiple sclerosis (MS). Objective Evaluating the proinflammatory (IL-17A) and anti-inflammatory (IL-10) cytokines in relapsing-remitting (RR) MS patients at time of relapse and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58521e10affbd25969c794c708d7ab28
https://pubmed.ncbi.nlm.nih.gov/28566181
https://pubmed.ncbi.nlm.nih.gov/28566181